Abstract
A multi-institutional phase II trial combining uracil-tegafur (UFT) and cisplatin (CDDP) was conducted in patients with previously untreated advanced non-small cell lung cancer (NSCLC) to evaluate the safety and efficacy of this combined treatment regimen. The entry criteria for this study were previously untreated NSCLC, measurable disease, age <80 years, performance status <2, and adequate haematological, hepatic and renal function. Patients were treated with 400 mg/m(2) oral UFT from day 1 to day 14 and 80 mg/m(2) cisplatin on day 15. The treatment course was repeated every 3 weeks. Of the 68 patients enrolled, 64 (27 with stage IIIB and 37 with stage IV disease) were eligible for treatment. Twenty of the 64 patients responded to the chemotherapy (response rate 31.3%; 95% CI 21.2-43.4%). The median survival time was 8.6 months, and the 1-year survival was 41.5%. Haematological toxicity >or=WHO grade 3 was seen in 3 (4.7%) patients. For non-haematological toxicities, anorexia with WHO grade 3 was seen in 8 (12.5%) patients, nausea and vomiting with WHO grade 3 in 4 (6.3%), diarrhoea with WHO grade 4 in 1 (1.6%), and liver dysfunction with WHO grade 4 in 1 (1.6%) patient. The combination of oral UFT plus cisplatin was found to...Continue Reading
References
Jul 1, 1979·The Laryngoscope·I K Arenberg
Jun 1, 1979·Contraception·J NewtonP Rowe
Jun 15, 1991·Cancer·F RichardsM R Green
Dec 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W HeimD Alt
Apr 1, 1986·Chest·C F Mountain
Nov 1, 1985·Cancer Treatment Reports·P L WeidenR H Rudolph
Dec 1, 1982·American Journal of Clinical Oncology·M M OkenP P Carbone
Oct 7, 1995·BMJ : British Medical Journal
Jun 1, 1995·Cancer·Y IchinoseM Ohta
Jan 1, 1993·Cancer Chemotherapy and Pharmacology·T ShirasakaM Fukushima
Feb 8, 1996·International Journal of Cancer. Journal International Du Cancer·T EsakiY Niho
Apr 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H WadaT Teramatsu
Jan 21, 2000·Cancer·Y IchinoseH Niitani
Feb 13, 2001·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·J SaitoT Nakabayashi
Jul 4, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K KellyD R Gandara
Jul 7, 2001·Seminars in Oncology·C Belani, UNKNOWN TAX 326 Study Group
Jan 11, 2002·The New England Journal of Medicine·Joan H SchillerUNKNOWN Eastern Cooperative Oncology Group
Oct 29, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Egbert F SmitUNKNOWN European Organization for Research and Treatment of Cancer Lung Cancer Group
Apr 23, 2004·The New England Journal of Medicine·Harubumi KatoUNKNOWN Japan Lung Cancer Research Group on Postsurgical Adjuvant Chemotherapy
Jul 30, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Chikuma HamadaHiromi Wada
Sep 22, 2005·British Journal of Cancer·Y IchinoseN Iwamoto
Citations
Feb 5, 2009·Respirology : Official Journal of the Asian Pacific Society of Respirology·Richard Ruffin, Philip G Bardin
Feb 5, 2009·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Tadashi IgishiEiji Shimizu
Oct 20, 2012·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Erin M BertinoMiguel A Villalona-Calero
Nov 26, 2015·PloS One·Mei PengGuangshi Tao
Feb 16, 2013·Health Technology Assessment : HTA·T BrownR Dickson